Brain-computer interfaces have a wide range of applications, and countless companies have long sought to obtain related technology licenses from Kechuang Bio and engage in various collaborations.
The same applies to European and American companies.
Just regarding brain-computer interface VR, major companies like Facebook, Microsoft, and Google have come to China for talks more than once.
Previously, the brain-computer interface VR technology was only authorized to Kechuang Future, and Kechuang Bio was even fined heavily by the Europa League for this.
This industrial VR event resulted in the technology being licensed to many Chinese companies.
European and American companies originally thought they had a chance to obtain technology licenses from Kechuang Biotechnology, but instead, China issued an administrative ban on them.
For a time, international media were full of criticism of China for using administrative means to interfere with normal business activities.
"China bans brain-computer interface technology from going overseas to protect its domestic manufacturing industry." This is a fairly normal headline for foreign media reports.
The slightly exaggerated ones are:
"China is practicing state monopoly."
"In order to gain a leading position in science and technology, China will stop at nothing in the technological competition."
We've seen plenty of Western media manipulating public opinion, but such blatant fabrication of facts is truly rare.
After these headlines and articles were reposted back to the Chinese internet, Chinese netizens, who pride themselves on their extensive knowledge, launched a counterattack.
In an interview, someone even stated bluntly:
"The United States has used a variety of excuses to suppress and sanction Chinese companies without cause, and these incidents are still fresh in our minds."
China's ban on the export of next-generation brain-computer interface technology is entirely for the purpose of protecting its own sensitive technologies.
We have not prohibited the export of brain-computer interface mobile phone technologies that have already been exported.
Western media, please stop with your double standards.
After the official confirmation that Kechuang Biotechnology had mastered the next generation of brain-computer interface technology, public opinion in China and even the world was in an uproar.
"What's going on? Our brain-computer interface with mobile phones has only achieved a 99% accuracy rate, while Kechuang Bio has already achieved a new generation of brain-computer interface technology?"
Zhang, why haven't I heard from you?
Zhang Weimin, formerly the vice president in charge of technology at Kechuang Biotechnology, was poached by Neuralink to serve as its general manager.
Under Zhang Weimin's leadership, Neuralink's latest brain-computer interface technology has achieved a 99% accuracy rate in neural signal recognition across both Chinese and English-related fields.
While this progress is far from Musk's expectations, it is still much better than previous research and development progress.
The only drawback is that although the technology has achieved a 99% accuracy rate in identification, it cannot bypass the patent barriers set up by Kechuang Biotechnology on some key points.
If the patent barriers set up by Kechuang Bio are completely bypassed, the identification accuracy rate can only reach 95%.
This recognition accuracy rate is second only to Kechuang Biotechnology worldwide.
Musk was just about to leverage his connections to make a big splash when he received news that Kechuang Bio had already developed the next generation of brain-computer interface technology.
He couldn't sit still any longer.
Wall Street views Neuralink and Sci-Tech Biotech as having a technological gap of about five years in the field of brain-computer interfaces.
This time lag is perfectly acceptable to Wall Street capital.
Brain-computer interface technology is extremely important; it can almost be said to be the most important prerequisite technology for virtual reality.
America can tolerate being technologically behind China in other areas, but it cannot tolerate being behind China in such a strategically important technology.
Neuralink's subsequent rounds of venture capital funding went very smoothly, with top American investment firms such as Morgan Stanley, Sequoia Capital, Goldman Sachs, and Bridgewater participating.
Investment institutions from Japan and the Europa League also got involved.
Zhang Weimin thought to himself that he had been away from Kechuang Biotechnology for almost two years, so how could he be so well-informed?
With Cheng Gang's departure, almost everyone in his network, from senior executives to middle managers, has been purged.
Even if Li Miaomiao doesn't do it, the Jiangcheng University faction around her will.
With the departure of senior and middle-level executives from the rice-producing faction represented by Cheng Gang, it will be easier for other factions to promote their own people.
Most of the senior executives in the rice industry have been eliminated, but some middle-level managers remain.
After Jiangda purged the senior executives of the rice-related faction, it began to split into two factions and started to fight each other.
Senior executives who graduated from the School of Economics and Management at Jiangnan University banded together, while those from the Faculty of Arts and Sciences, such as Mathematics, Biology, and Physics, banded together.
The majority of senior executives are from the School of Economics and Management, while graduates from the School of Science at Jiangnan University hold an absolute majority in middle management positions.
As long as interests are involved, the struggle between people is hard to stop.
Of course, none of this has much to do with Zhang Weimin, who is the general manager of Neuralink.
Because of Zhang Weimin's position at Neuralink, several senior executives from the US-based companies were able to transfer to middle management positions at Neuralink through his connections.
Faced with Musk's questioning, Zhang Weimin calmly replied, "Elon, I will obtain first-hand information about Kechuang Bio as soon as possible."
"In my opinion, Kechuang Bio's brain-computer interface technology has undoubtedly achieved a breakthrough."
The statements made by the Chinese government as an official entity have a certain degree of credibility.
What we need to do now is to bring our brain-computer interface technology to market as soon as possible.
Even if it infringes on the patent rights of Kechuang Biotechnology, there is no need to worry.
It's nothing more than patent litigation.
This chapter is not finished, please click the next page to continue reading!
Continue read on readnovelmtl.com
